BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 13, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 9, 2009
View Archived Issues
Anadys Soars 115 percent on Strong Hepatitis C Virus Data
Read More
Senate HELP Committee Grills Daschle about Health Reform
Read More
Vivaldi Raises $23M Financing for Older Adult Flu Vaccines
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Pharma Still Keen for Vaccines; Wyeth, Crucell in Merger Talks
Dutch vaccines maker Crucell NV confirmed that it was talking to Wyeth about a possible merger after reports surfaced Wednesday afternoon that the big pharma firm was interested in an acquisition. (BioWorld Today)
Read More
Plexxikon Rejoins with Roche in $335M Deal for Raf Inhibitors
Read More